Avalo Therapeutics Financial Health
How is Avalo Therapeutics's financial position?
Financial Health Score
0/6Financial Health Score 0/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: AVTX has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: AVTX has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: AVTX has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: AVTX's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AVTX has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: AVTX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 42.8% each year